Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M Clemente Andújar"'
Autor:
B Serna Serrano, M Diaz Rangel, S Ruiz Sánchez, S Plata Paniagua, I Casas Hidalgo, F Sánchez Rubio, M Clemente Andújar, A Valladolid Walsh
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Ibrutinib is a potent Burton tyrosine kinase inhibitor involved in the proliferation and survival of chronic lymphatic leukaemia (CLL) B cells. This study was mainly motivated by suspensions for toxicity. Aim and objectives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58f32f7e00c13f22ec1296c8778844f7
https://doi.org/10.1136/ejhpharm-2021-eahpconf.124
https://doi.org/10.1136/ejhpharm-2021-eahpconf.124
Autor:
S Plata Paniagua, E Tebar Martínez, H Alabort Ayllón, M Del Pozo Carlavilla, M Sáez Garrido, M Clemente Andújar, S Ruiz Sánchez, J. M. Collado Sanz, B Serna Serrano, C Del Pozo Carlavilla
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tocilizumab (TCZ) is an immunosuppressor drug, IL-6 inhibitor, indicated for the treatment of rheumatoid arthritis and cytokine release syndrome associated with CAR T cell therapy. It was proposed as a compassionate treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d9c182bbf7d34331eea0fbca09ac21
https://doi.org/10.1136/ejhpharm-2021-eahpconf.164
https://doi.org/10.1136/ejhpharm-2021-eahpconf.164
Autor:
M Clemente Andújar, B Serna Serrano, S Ruiz Sánchez, H Alabort Ayllón, C Del Pozo Carlavilla, M Sáez Garrido, S Plata Paniagua, E Tebar Martínez, M Del Pozo Carlavilla, CS Juan Manuel
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tocilizumab (TCZ) is an immunosuppressor drug, IL-6 inhibitor, indicated for the treatment of rheumatoid arthritis and cytokine release syndrome associated with CAR T cell therapy It was proposed as a compassionate treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f7a4e587592c9385f96ae1d60b440a
https://doi.org/10.1136/ejhpharm-2021-eahpconf.163
https://doi.org/10.1136/ejhpharm-2021-eahpconf.163
Autor:
A Valladolid Walsh, A Serrano Martínez, I Pérez Alpuente, V Lerma Gaude, B Serna Serrano, M Clemente Andújar, R. Aldaz Francés
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Fidaxomicin is a macrolide antibiotic used to treat intestinal Clostridium difficile (CD) infection in the absence of metronidazole or vancomycin treatments. Pharmacovigilance collects information, and analyses and notifies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0976c9a6c79756bc4ff1ffbc47547380
https://doi.org/10.1136/ejhpharm-2021-eahpconf.240
https://doi.org/10.1136/ejhpharm-2021-eahpconf.240
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N Monteagudo Martínez, G Romero Candel, N Jimenez Collados, A Valladolid Walsh, S Plata Paniagua, M Clemente Andújar, C García Gómez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A104.3-A104
Background Romiplostim was approved in 2009 to treat adult splenectomised patients with chronic Idiopathic Thrombocytopenic Purpura (ITP) when refractory to other treatment. It is also considered second-line treatment in non-splenectomised patients i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b235eda4e3acae1c510ff483f900d9f5
https://doi.org/10.1136/ejhpharm-2015-000639.251
https://doi.org/10.1136/ejhpharm-2015-000639.251
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 28(4)
To establish the percentage of Pharmacy Departments with a web site on the Net, and to analyze whether their contents are focused on the development of pharmaceutical care activities for outpatients.Cross-sectional study based on multiple Internet se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d922c3f46cc29def034efae9a5dd9d6
https://pubmed.ncbi.nlm.nih.gov/15369439
https://pubmed.ncbi.nlm.nih.gov/15369439
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.